JPH10313865A5 - - Google Patents

Info

Publication number
JPH10313865A5
JPH10313865A5 JP1997125965A JP12596597A JPH10313865A5 JP H10313865 A5 JPH10313865 A5 JP H10313865A5 JP 1997125965 A JP1997125965 A JP 1997125965A JP 12596597 A JP12596597 A JP 12596597A JP H10313865 A5 JPH10313865 A5 JP H10313865A5
Authority
JP
Japan
Prior art keywords
viral vector
membrane
inhibits
factor
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997125965A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10313865A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP9125965A priority Critical patent/JPH10313865A/ja
Priority claimed from JP9125965A external-priority patent/JPH10313865A/ja
Publication of JPH10313865A publication Critical patent/JPH10313865A/ja
Publication of JPH10313865A5 publication Critical patent/JPH10313865A5/ja
Pending legal-status Critical Current

Links

JP9125965A 1997-05-15 1997-05-15 ヒト補体制御因子が呈示されたベクター Pending JPH10313865A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9125965A JPH10313865A (ja) 1997-05-15 1997-05-15 ヒト補体制御因子が呈示されたベクター

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9125965A JPH10313865A (ja) 1997-05-15 1997-05-15 ヒト補体制御因子が呈示されたベクター

Publications (2)

Publication Number Publication Date
JPH10313865A JPH10313865A (ja) 1998-12-02
JPH10313865A5 true JPH10313865A5 (enExample) 2004-11-18

Family

ID=14923367

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9125965A Pending JPH10313865A (ja) 1997-05-15 1997-05-15 ヒト補体制御因子が呈示されたベクター

Country Status (1)

Country Link
JP (1) JPH10313865A (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3543106B2 (ja) 1999-07-21 2004-07-14 大阪大学長 膜結合型ｃ１インアクチベーター
JP5050198B2 (ja) * 2006-09-05 2012-10-17 国立大学法人大阪大学 ヒト補体制御因子発現遺伝子およびその利用
CN104530241B (zh) * 2014-12-15 2018-05-18 武汉市畜牧兽医科学研究所 一种表达穿膜肽融合蛋白的基因工程菌及应用
AU2018265258B2 (en) * 2017-05-10 2023-01-05 Pharma Cinq, Llc Enveloped virus resistant to complement inactivation for the treatment of cancer
WO2020014209A1 (en) 2018-07-09 2020-01-16 Flagship Pioneering Innovations V, Inc. Fusosome compositions and uses thereof
AU2019378036B2 (en) 2018-11-14 2026-05-07 Flagship Pioneering Innovations V, Inc Compositions and methods for compartment-specific cargo delivery
WO2020102503A2 (en) * 2018-11-14 2020-05-22 Flagship Pioneering Innovations V, Inc. Fusosome compositions for t cell delivery
CA3120082A1 (en) * 2018-11-14 2020-05-22 Flagship Pioneering Innovations V, Inc. Fusosome compositions for cns delivery
WO2022182206A1 (ko) * 2021-02-26 2022-09-01 신라젠(주) 항암 바이러스 및 이의 용도

Similar Documents

Publication Publication Date Title
Moulin et al. Extracellular vesicles and viruses: two intertwined entities
Schlender et al. Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection
Jayakar et al. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release
Reil et al. Efficient HIV‐1 replication can occur in the absence of the viral matrix protein
JP2018506983A5 (enExample)
Verhoeyen et al. Surface‐engineering of lentiviral vectors
JP2004501647A5 (enExample)
JP2019509063A5 (enExample)
Mebatsion et al. Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein.
DK0809700T3 (da) Papillomaviruslignende partikler, fusionsproteiner samt fremgangsmåde til fremstilling heraf
KR960703169A (ko) 고역가 바이러스 생산과 포유류 세포의 고효율 레트로바이러스 중개된 형질도입 방법(method for rroduction of high titer virus and high efficiency retroviral mediated transduction of mammalian cells)
EP1369427A3 (en) HIV-3 retrovirus strains and their use
WO2023115039A3 (en) Modified paramyxoviridae fusion glycoproteins
JP2003514565A5 (enExample)
RU2012140691A (ru) Вакцины на основе неинтегрирующегося ретровирусного вектора
AU3103195A (en) Secreted viral proteins useful for vaccines and diagnostics
Teysset et al. A Moloney murine leukemia virus-based retroviral vector pseudotyped by the insect retroviral gypsy envelope can infect Drosophila cells
Sjöberg et al. Interactions between the transmembrane segments of the alphavirus E1 and E2 proteins play a role in virus budding and fusion
JP2007502623A (ja) 膜タンパク質におけるフリンプロテアーゼ開裂部位の挿入およびその使用法
Kolesnikova et al. Vacuolar protein sorting pathway contributes to the release of Marburg virus
IL134978A0 (en) Membrane virus host range mutations and their uses as vaccine substrates
KR880701283A (ko) Aids의 원인이 되는 비루스의 당단백질을 암호화하는 비루스 벡터, 백신 및 항체
CN116554349A (zh) 嵌合病毒包膜糖蛋白及包含其的载体
Vincent et al. Intracellular interaction of simian immunodeficiency virus Gag and Env proteins
JP2004509601A5 (enExample)